相关实验视频

Updated: May 10, 2025

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

多变量预测模型可疑的眼睛肌痛严重症:开发和验证

Armin Handzic¹, Marius P Furter, Brigitte C Messmer

¹Department of Ophthalmology (AH, BCM, MAW, FCF, KPW), University Hospital Zurich, University of Zurich, Zurich, Switzerland; University of Toronto (AH, EAM), Faculty of Medicine, Department of Ophthalmology and Vision Sciences, Toronto, Ontario, Canada; Institute for Mathematics (IMATH) (MPF), University of Zurich, Zurich, Switzerland; Department of Neurology (YV, KPW), University Hospital Zurich, University of Zurich, Zurich, Switzerland; and Division of Neurology, Department of Medicine (EAM), Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

|April 21, 2025

概括

诊断眼部骨髓质疏松症 (OMG) 是一个挑战. 一个新的预测模型使用诊断测试结果来估计OMG概率,帮助临床决策.

科学领域:

神经学神经学
眼科医生眼科眼科
医学诊断医学诊断医学诊断

背景情况:

诊断眼部肌痛性肌痛症 (OMG) 提出了重大挑战,即使在最近的进展.
准确和及时的诊断对于有效的患者管理至关重要.

研究的目的:

开发和验证一个多变量预测模型来估计OMG概率.
根据诊断测试结果提供转基因生物的可能性,以协助临床医生做出决策.

主要方法:

使用前性诊断准确性研究的数据开发了贝叶斯网络模型.
该模型是通过多个机构的回顾性患者数据进行训练和验证的.
确定了关键的诊断变量,并根据预测值进行排名.

主要成果:

预测模型确定了和乙胆受体 (AChR) 抗体作为OMG最强的预测因子.
验证证明了高的预测准确性,以0.912的EDROPHONIUM测试曲线下的面积 (AUC) 和0.872的ACHR抗体.
纳入额外的诊断变量改善了该模型的整体预测误差.

结论:

开发的预测模型是一个经过验证的工具,用于估计眼球肌痛严重症的可能性.
该模型可以通过整合各种诊断测试结果来支持临床决策.
进一步整合预测因素可以提高OMG的诊断准确性.

更多相关视频

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...